Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Hematology & Oncology|November 23, 2019
Chimeric antigen receptor T cell therapies for multiple myelomaChao Wu, Lina Zhang, Qierra R Brockman, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistanceJeff Rytlewski, Qierra R Brockman, Rebecca D Dodd, et al.
Scientific Reports|January 14, 2021
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor modelsWade R Gutierrez, Amanda Scherer, Gavin R McGivney, et al.
Current Issues in Molecular Biology|February 24, 2023
Loss of Nf1 and Ink4a/Arf Are Associated with Sex-Dependent Growth Differences in a Mouse Model of Embryonal RhabdomyosarcomaWade R Gutierrez, Jeffrey D Rytlewski, Amanda Scherer, et al.
Scientific Reports|September 8, 2023
Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis modelsQierra R Brockman, Amanda Scherer, Gavin R McGivney, et al.
JCI Insight|September 6, 2022
PRC2 loss drives MPNST metastasis and matrix remodelingQierra R Brockman, Amanda Scherer, Gavin R McGivney, et al.
JCI Insight|October 13, 2022
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanismWade R Gutierrez, Amanda Scherer, Jeffrey D Rytlewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
A single arm phase 2 trial of doxorubicin plus zalifrelimab (anti-CTLA-4 antibody) and balstilimab (anti-PD-1 antibody) in advanced/metastatic soft tissue sarcomasBreelyn A Wilky, Katherine A Julian, Alessandra Maleddu, et al.
Science Advances|August 13, 2025
Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTsGavin R McGivney, Qierra R Brockman, Nicholas Borcherding, et al.
Pageof 2